ATOS

Atossa Genetics (ATOS) P/E Ratio
P/E Ratio as of Oct 26, 2026: -0.56
Average-0.5633
Median-0.5600
Minimum-0.6700
Maximum-0.4500
-0.56
0.12 (27.27%)past month
The P/E ratio for Atossa Genetics (ATOS) is -0.56 as of Oct 26, 2026. This represents a decrease of -61.90% compared to its 12-month average P/E ratio of -1.47. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Atossa Genetics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Atossa Genetics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Atossa Genetics to industry peers.
Atossa Genetics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Atossa Genetics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Atossa Genetics to industry peers.
Atossa Genetics (ATOS) P/E Ratio Insights
See Atossa Genetics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Atossa Genetics (ATOS)
Order type
Buy in
Order amount
Est. shares
0 shares
Atossa Genetics (ATOS) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $2.27 | -0.52 |
| Sep 1, 2026 | $2.42 | -0.56 |
| Aug 3, 2026 | $2.17 | -0.50 |
| Jul 1, 2026 | $2.04 | -0.47 |
| Jun 1, 2026 | $5.11 | -1.17 |
| May 1, 2026 | $5.33 | -1.32 |
| Apr 1, 2026 | $5.11 | -1.27 |
| Mar 2, 2026 | $4.50 | -1.28 |
| Feb 2, 2026 | $5.59 | -1.38 |
| Jan 2, 2026 | $9.459 | -2.34 |
Atossa Genetics (ATOS) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.56 | -74.43% |
| 2025 | -2.19 | -53.00% |
| 2024 | -4.66 | +24.93% |
| 2023 | -3.73 | +35.64% |
| 2022 | -2.75 | -69.88% |
| 2021 | -9.13 | — |
FAQs About Atossa Genetics (ATOS) P/E ratio
The latest P/E ratio of Atossa Genetics (ATOS) is -0.56, as of Oct 26, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Atossa Genetics’s last 12-month average P/E ratio is -1.47, compared to its current P/E ratio of -0.56. This reflects a decrease of -61.90%.
Atossa Genetics’s current P/E ratio of -0.56 is lower than its last 12-month average P/E of -1.47. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Atossa Genetics’s average P/E ratio over the last 3 years is -3.68. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Atossa Genetics’s average P/E ratio over the last 5 years is -4.11. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Atossa Genetics (ATOS) P/E Ratio Insights
See Atossa Genetics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Atossa Genetics (ATOS)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.